1,029
Views
11
CrossRef citations to date
0
Altmetric
Extra Views

FMN2 is a novel regulator of the cyclin-dependent kinase inhibitor p21

, , , &
Pages 2348-2354 | Received 25 May 2013, Accepted 23 Jun 2013, Published online: 01 Jul 2013

References

  • Ozenne P, Eymin B, Brambilla E, Gazzeri S. The ARF tumor suppressor: structure, functions and status in cancer. Int J Cancer 2010; 127:2239 - 47; http://dx.doi.org/10.1002/ijc.25511; PMID: 20549699
  • Vousden KH, Lane DP. p53 in health and disease. Nat Rev Mol Cell Biol 2007; 8:275 - 83; http://dx.doi.org/10.1038/nrm2147; PMID: 17380161
  • Yamada K, Ono M, Perkins ND, Rocha S, Lamond AI. Identification and functional characterization of FMN2, a regulator of the cyclin-dependent kinase inhibitor p21. Mol Cell 2013; 49:922 - 33; http://dx.doi.org/10.1016/j.molcel.2012.12.023; PMID: 23375502
  • Yu J, Zhang L. The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun 2005; 331:851 - 8; http://dx.doi.org/10.1016/j.bbrc.2005.03.189; PMID: 15865941
  • Larance M, Ahmad Y, Kirkwood KJ, Ly T, Lamond AI. Global subcellular characterization of protein degradation using quantitative proteomics. Mol Cell Proteomics 2013; 12:638 - 50; http://dx.doi.org/10.1074/mcp.M112.024547; PMID: 23242552
  • Ahmad Y, Boisvert FM, Lundberg E, Uhlen M, Lamond AI. Systematic analysis of protein pools, isoforms, and modifications affecting turnover and subcellular localization. Mol Cell Proteomics 2012; 11:013680; http://dx.doi.org/10.1074/mcp.M111.013680; PMID: 22002106
  • Boisvert FM, Ahmad Y, Gierliński M, Charrière F, Lamont D, Scott M, et al. A quantitative spatial proteomics analysis of proteome turnover in human cells. Mol Cell Proteomics 2012; 11:011429; http://dx.doi.org/10.1074/mcp.M111.011429; PMID: 21937730
  • Lam YW, Lamond AI, Mann M, Andersen JS. Analysis of nucleolar protein dynamics reveals the nuclear degradation of ribosomal proteins. Curr Biol 2007; 17:749 - 60; http://dx.doi.org/10.1016/j.cub.2007.03.064; PMID: 17446074
  • Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 2009; 9:400 - 14; http://dx.doi.org/10.1038/nrc2657; PMID: 19440234
  • Romanov VS, Pospelov VA, Pospelova TV. Cyclin-dependent kinase inhibitor p21(Waf1): contemporary view on its role in senescence and oncogenesis. Biochemistry (Mosc) 2012; 77:575 - 84; http://dx.doi.org/10.1134/S000629791206003X; PMID: 22817456
  • Leader B, Lim H, Carabatsos MJ, Harrington A, Ecsedy J, Pellman D, et al. Formin-2, polyploidy, hypofertility and positioning of the meiotic spindle in mouse oocytes. Nat Cell Biol 2002; 4:921 - 8; http://dx.doi.org/10.1038/ncb880; PMID: 12447394
  • Faix J, Grosse R. Staying in shape with formins. Dev Cell 2006; 10:693 - 706; http://dx.doi.org/10.1016/j.devcel.2006.05.001; PMID: 16740473
  • Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 2008; 26:1367 - 72; http://dx.doi.org/10.1038/nbt.1511; PMID: 19029910
  • Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M. Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res 2011; 10:1794 - 805; http://dx.doi.org/10.1021/pr101065j; PMID: 21254760
  • Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER 3rd, Hurov KE, Luo J, et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007; 316:1160 - 6; http://dx.doi.org/10.1126/science.1140321; PMID: 17525332
  • Rocha S, Perkins ND. ARF the integrator: linking NFκB, p53 and checkpoint kinases. Cell Cycle 2005; 4:756 - 9; http://dx.doi.org/10.4161/cc.4.6.1739; PMID: 15970704
  • Szklarczyk R, Heringa J, Pond SK, Nekrutenko A. Rapid asymmetric evolution of a dual-coding tumor suppressor INK4a/ARF locus contradicts its function. Proc Natl Acad Sci U S A 2007; 104:12807 - 12; http://dx.doi.org/10.1073/pnas.0703238104; PMID: 17652172
  • Kim SH, Mitchell M, Fujii H, Llanos S, Peters G. Absence of p16INK4a and truncation of ARF tumor suppressors in chickens. Proc Natl Acad Sci U S A 2003; 100:211 - 6; http://dx.doi.org/10.1073/pnas.0135557100; PMID: 12506196
  • Charfi C, Voisin V, Levros LC Jr., Edouard E, Rassart E. Gene profiling of Graffi murine leukemia virus-induced lymphoid leukemias: identification of leukemia markers and Fmn2 as a potential oncogene. Blood 2011; 117:1899 - 910; http://dx.doi.org/10.1182/blood-2010-10-311001; PMID: 21135260
  • Rocha S, Campbell KJ, Perkins ND. p53- and Mdm2-independent repression of NFkappa B transactivation by the ARF tumor suppressor. Mol Cell 2003; 12:15 - 25; http://dx.doi.org/10.1016/S1097-2765(03)00223-5; PMID: 12887889
  • Rocha S, Garrett MD, Campbell KJ, Schumm K, Perkins ND. Regulation of NFκB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor. EMBO J 2005; 24:1157 - 69; http://dx.doi.org/10.1038/sj.emboj.7600608; PMID: 15775976
  • Msaki A, Sánchez AM, Koh LF, Barré B, Rocha S, Perkins ND, et al. The role of RelA (p65) threonine 505 phosphorylation in the regulation of cell growth, survival, and migration. Mol Biol Cell 2011; 22:3032 - 40; http://dx.doi.org/10.1091/mbc.E11-04-0280; PMID: 21737676
  • Campbell KJ, Witty JM, Rocha S, Perkins ND. Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-kappaB transactivation. Cancer Res 2006; 66:929 - 35; http://dx.doi.org/10.1158/0008-5472.CAN-05-2234; PMID: 16424027